Mind Medicine (STU:MMQ) EV-to-EBIT : -6.81 (As of May. 04, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Mind Medicine EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mind Medicine's Enterprise Value is €593.11 Mil. Mind Medicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-87.04 Mil. Therefore, Mind Medicine's EV-to-EBIT for today is -6.81.

The historical rank and industry rank for Mind Medicine's EV-to-EBIT or its related term are showing as below:

STU:MMQ' s EV-to-EBIT Range Over the Past 10 Years
Min: -54.95 Med: 0 Max: 1.12
Current: -6.75

During the past 4 years, the highest EV-to-EBIT of Mind Medicine was 1.12. The lowest was -54.95. And the median was 0.00.

STU:MMQ's EV-to-EBIT is ranked worse than
100% of 434 companies
in the Biotechnology industry
Industry Median: 8.915 vs STU:MMQ: -6.75

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Mind Medicine's Enterprise Value for the quarter that ended in Dec. 2023 was €58.56 Mil. Mind Medicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-87.04 Mil. Mind Medicine's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -148.63%.

Mind Medicine EV-to-EBIT Historical Data

The historical data trend for Mind Medicine's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine EV-to-EBIT Chart

Mind Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-25.32

-4.77

0.88

-0.69

Mind Medicine Quarterly Data
	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial												0.88	0.12	-0.27	-0.26	-0.69

Competitive Comparison of Mind Medicine's EV-to-EBIT

For the Biotechnology subindustry, Mind Medicine's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mind Medicine's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mind Medicine's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mind Medicine's EV-to-EBIT falls into.

Mind Medicine EV-to-EBIT Calculation

Mind Medicine's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	593.110	/	-87.038
	=	-6.81

Mind Medicine's current Enterprise Value is €593.11 Mil.
Mind Medicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-87.04 Mil.

Mind Medicine (STU:MMQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Mind Medicine's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-87.038	/	58.5587342
	=	-148.63 %

Mind Medicine's Enterprise Value for the quarter that ended in Dec. 2023 was €58.56 Mil.
Mind Medicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-87.04 Mil.

Mind Medicine EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Mind Medicine's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine (STU:MMQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (STU:MMQ) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

MNMD:USA MMED:Canada

Address

One World Trade Center, Suite 8500, New York, NY, USA, 10007

Website

https://www.mindmed.co

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Mind Medicine (STU:MMQ) Headlines

No Headlines